A study comparing Dihydroartemisinin-piperaquine with artesunate-amodiaquine for treatment of malaria infection in pregnancy in Ghana.

Trial Profile

A study comparing Dihydroartemisinin-piperaquine with artesunate-amodiaquine for treatment of malaria infection in pregnancy in Ghana.

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Sep 2017

At a glance

  • Drugs Dihydroartemisinin/piperaquine (Primary) ; Artesunate/amodiaquine
  • Indications Malaria
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Sep 2017 New trial record
    • 01 Aug 2017 Primary endpoint (Parasitological efficacy (PE)) has been met as per the results published in the Tropical Medicine and International Health
    • 01 Aug 2017 Results published in the Tropical Medicine and International Health
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top